Please assess the completion status of the following clinical trial:

Trial Title: TX2® Low Profile TAA Endovascular Graft

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Descending thoracic aneurysm with diameter ≥ 5.0 cm~* Descending thoracic aneurysm with a history of growth ≥ 0.5 cm per year~* Descending thoracic degenerative or atherosclerotic ulcer ≥ 10 mm in depth and 20 mm in diameter~Exclusion Criteria:~* Less than 18 years of age~* Life expectancy less than 2 years~* Pregnant or breastfeeding or planning on becoming pregnant within 60 months~* Unwilling to comply with the follow-up schedule~* Inability or refusal to give informed consent~* Less than 30 days beyond primary endpoint for other investigative drug or device study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): Zenith® TX2® Low Profile TAA Endovascular Graft (Thoracic Aortic Aneurysm)

Based on this trial design, predict the completion outcome and termination type (if applicable).